Section Arrow
BOLD.NASDAQ
- Boundless Bio
Quotes are at least 15-min delayed:2024/05/16 17:04 EDT
Last
 9.96
+0.43 (+4.51%)
Day High 
9.98 
Prev. Close
9.53 
1-M High
12.6484 
Volume 
50.20K 
Bid
9.2
Ask
9.96
Day Low
8.945 
Open
9.14 
1-M Low
8.51 
Market Cap 
211.94M 
Currency USD 
P/E -- 
%Yield
10-SMA 9.41 
20-SMA 10.11 
50-SMA -- 
52-W High 15.24 
52-W Low 8.51 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.53/--
Enterprise Value
211.94M
Balance Sheet
Book Value Per Share
-5.71
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1001+0.0224+28.83%-- 
DNAGinkgo Bioworks Holdings0.839-0.0001-0.01%-- 
NBYNovaBay Pharmaceuticals0.12+0.0155+14.83%-- 
JAGXJaguar Health0.2867+0.0316+12.39%-- 
NVAXNovavax14.4+1.5+11.63%-- 
Quotes are at least 15-min delayed:2024/05/16 17:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.